Teva earnings Q2 2018 | AlphaStreet
Earnings Preview: What To Expect From Teva Pharmaceutical On Thursday
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva Pharmaceutical: Earnings Trends and Recent Developments
Here's Why Teva Shares are Trending Higher Today
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations - Simply Wall St News
Teva Shares Spike After Q1 Earnings Beat, Full Year Forecast Boost - TheStreet
Teva Earnings: Is It Time to Worry? | Barron's
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror – PharmaLive
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva soars after earnings beat, increased guidance - TheStreet
Teva Pharmaceuticals Q4 2016 Earnings
Teva Stock Falls After Earnings and Revenue Miss Estimates | Barron's
Teva Pharmaceutical earnings per share 2006-2021 | Statista
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Earnings season continues: BMS revenue inches up, Teva lowers outlook
Teva Pharmaceutical Industries Limited 2018 Q2 - Results - Earnings Call Slides (NYSE:TEVA) | Seeking Alpha
TEVA Stock | Teva Pharmaceuticals Q2 2020 Earnings Call - YouTube
Teva tumbles as sales and earnings underwhelm
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva ADR Earnings, Revenue Miss in Q3 By Investing.com
Teva Pharmaceutical Is in Recovery - WSJ
